Skip to main content
OpenTrials
Completed

NCT Number: NCT05476666

Peripheral Venous Pressure as an Indicator of Central Venous Pressure in Post Operative Surgical Patients: A Randomised Controlled Trial

The study is aimed at comparing peripherial venous pressure as an indicator of central venous pressure in post operative surgical patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

PNS Shifa Hospital

Karachi, Sindh, 46000, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ASA I/II/III surgical patients who require central venous access as part of their surgical treatment plan with no organ support in post operative period.
  • Age between 18 and 75 years
  • Who have atleast 1 x 18 gauge peripherial venous cannula in the upper limb from elbow below to the hand
  • Who have given consent

Exclusion criteria

  • Not meeting the inclusion criteria

Treatment and study plan

Peripherial and central venous access

Procedure

Passing a peripherial and a central venous catheter/cannula

Primary outcomes

  1. Peripherial venous pressure as an indicator of central venous pressure

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Pakistan Navy Station Shifa Hospital

Other

Registry information

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Jul 27, 2022
Registry last updated
Aug 3, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.